| Product Code: ETC7179144 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Fiji`s import shipments of live biotherapeutic products and microbiome CDMO services continued to be dominated by key exporting countries such as New Zealand, USA, Australia, India, and Taiwan, Province of China in 2024. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained very high, indicating a concentrated market structure. However, the industry experienced a significant decline in compound annual growth rate (CAGR) of -57.08% from 2020 to 2024, with a further decrease in growth rate from 2023 to 2024 at -57.1%. This suggests a challenging environment for the sector in Fiji.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Live Biotherapeutic Products And Microbiome CDMO Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Live Biotherapeutic Products And Microbiome CDMO Market - Industry Life Cycle |
3.4 Fiji Live Biotherapeutic Products And Microbiome CDMO Market - Porter's Five Forces |
3.5 Fiji Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Fiji Live Biotherapeutic Products And Microbiome CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Fiji Live Biotherapeutic Products And Microbiome CDMO Market Trends |
6 Fiji Live Biotherapeutic Products And Microbiome CDMO Market, By Types |
6.1 Fiji Live Biotherapeutic Products And Microbiome CDMO Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Fiji Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Fiji Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, By C.difficle, 2021- 2031F |
6.1.4 Fiji Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, By Crohns disease, 2021- 2031F |
6.1.5 Fiji Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, By IBS, 2021- 2031F |
6.1.6 Fiji Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.1.7 Fiji Live Biotherapeutic Products And Microbiome CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Fiji Live Biotherapeutic Products And Microbiome CDMO Market Import-Export Trade Statistics |
7.1 Fiji Live Biotherapeutic Products And Microbiome CDMO Market Export to Major Countries |
7.2 Fiji Live Biotherapeutic Products And Microbiome CDMO Market Imports from Major Countries |
8 Fiji Live Biotherapeutic Products And Microbiome CDMO Market Key Performance Indicators |
9 Fiji Live Biotherapeutic Products And Microbiome CDMO Market - Opportunity Assessment |
9.1 Fiji Live Biotherapeutic Products And Microbiome CDMO Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Fiji Live Biotherapeutic Products And Microbiome CDMO Market - Competitive Landscape |
10.1 Fiji Live Biotherapeutic Products And Microbiome CDMO Market Revenue Share, By Companies, 2024 |
10.2 Fiji Live Biotherapeutic Products And Microbiome CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |